NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Elmed Life Sciences

Elmed Life Sciences

Private
HyderabadHealthcare & Life Scienceshttps://www.elmedprobiotics.com/

Last Round

Series A

Mar 26, 2026

Total Funding Raised

$2.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Elmed Life Sciences is a biotechnology company that manufactures probiotic and biological solutions for animal health, agriculture, aquaculture, and human health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOprobiotic manufacturingnutraceutical manufacturingcontract manufacturingprivate labelingbiotech manufacturingsupplement contract manufacturermicrobiome solutionscustom formulationagrobioticsWHO-GMP certifiedmicrobial formulationsQbDquality by designwhite label supplements

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elmed Life Sciences Comps

Public and private peers based on sector, stage, and business model.

Elmed Life Sciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Elmed Life Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 26, 2026

Elmed Life Sciences Investors

Notable investors and investment history

Elmed Life Sciences investors
InvestorRounds
NABVENTURES LimitedSeries A
NABVENTURESSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    $3M round raised

Elmed Life Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elmed Life Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elmed Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersHyderabad
Year Founded2018
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.